FDA Approves 2 Therapies for Treatment of Metastatic Non-Small Cell Lung Cancer

Lung Cancer
02/07/2020

Wright KM. Oncology (Williston Park) 2020.

ABSTRACT

The FDA approved 2 new therapies, each with its own companion diagnostic, for the treatment of patients with metastatic non-small cell lung cancer.